AJCC Cancer Staging System Version 9: Appendiceal Adenocarcinoma Nader HannaAndrew N. HannaDavid N. Hanna Gastrointestinal Oncology 19 January 2024 Pages: 2177 - 2180
Educating Cancer-Associated Fibroblasts (CAFs): Are They the Student or the Teacher? Ajay V. MakerGiorgos Karakousis Gastrointestinal Oncology 05 January 2024 Pages: 2181 - 2182
Psychological Interventions in Prehabilitation Randomized Controlled Trials for Patients Undergoing Cancer Surgery: Sufficient or Suboptimal? Nicholas HirstKate McBrideDaniel Steffens Translational Research 20 January 2024 Pages: 2183 - 2186
Primary Tumor Resection and Its Implications in the Modern Treatment Era of Metastatic Small Bowel Neuroendocrine Tumors Xavier M. Keutgen Endocrine Tumors 02 January 2024 Pages: 2187 - 2189
Centralized Care of the Surgical Oncology Patient: A Simple Task with Complex Solutions Gregor WerbaAmer H. Zureikat Pancreatic Tumors 15 January 2024 Pages: 2190 - 2191
Evolution of Surgical Management and Outcomes of Neuroendocrine Tumor Liver Metastases Ricardo J. BelloCallisia N. Clarke Hepatobiliary Tumors 25 January 2024 Pages: 2192 - 2193
Reconnaissance for Intraperitoneal Immunotherapy Edward A. Levine Peritoneal Surface Malignancy 23 January 2024 Pages: 2194 - 2195
The Search for Cancer Using Light Having Longer Wavelength Junji IchinoseAkihiko Okamura Thoracic Oncology 03 January 2024 Pages: 2196 - 2197
Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations Shinji Mine Thoracic Oncology 25 January 2024 Pages: 2198 - 2199
Staying a Step Ahead: Tailoring Chemotherapy for Esophageal Cancer Sadia TasnimMonisha Sudarshan Thoracic Oncology 09 February 2024 Pages: 2200 - 2201
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancers Amber Leila SarvestaniJacob LambdinMark E. Zafereo ASO Research Letter 20 January 2024 Pages: 2202 - 2203
What Defines the Value of Minimally Invasive Surgery for Cancer Patients? Yuki HirataHeather LyuNaruhiko Ikoma ASO Research Letter 20 December 2023 Pages: 2204 - 2207
Nonlinear Associations of Visceral and Perirenal Fat with Short-Term Postoperative Complications in Clear Cell Renal Cell Carcinoma Patients Zehua SunYuanhao XiaHeng Ma ASO Research Letter 22 January 2024 Pages: 2208 - 2211
Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks Puneet SinghDoreen AgneseJudy Boughey Breast Oncology 23 January 2024 Pages: 2212 - 2223
Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management Shlermine A. EveridgeJia SunPuneet Singh Breast Oncology 20 December 2023 Pages: 2224 - 2230
Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype? Natália PolidorioGiacomo MontagnaMonica Morrow Breast Oncology 29 December 2023 Pages: 2231 - 2243
Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer Tessa HigginsOlga KantorElizabeth A. Mittendorf Breast Oncology 31 December 2023 Pages: 2244 - 2252
Breast Cancer Screening and BI-RADS Scoring Trends Before and During the COVID-19 Pandemic in an Academic Safety-Net Hospital Anna Kobzeva-HerzogThomas O’SheaMichael R. Cassidy Breast Oncology 04 January 2024 Pages: 2253 - 2260
A Feasibility Randomized Controlled Trial of Prehabilitation During Neoadjuvant Chemotherapy for Women with Breast Cancer: A Mixed Methods Study Priya BrahmbhattNicole J. Look HongFrances C. Wright Breast Oncology 13 January 2024 Pages: 2261 - 2271
ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials? Pieter WestenendClaudia MeursSabine Siesling ASO Author Reflections 25 January 2024 Pages: 2272 - 2273
ASO Author Reflections: Refining Radiotherapy Decisions in T3N0M0 Breast Cancer: A Nomogram-Based Approach Xiangdi MengNan WangYingxiao Jiang ASO Author Reflections 23 December 2023 Pages: 2274 - 2275
ASO Visual Abstract: Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy—Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management Shlermine A. EveridgeJia SunPuneet Singh ASO Visual Abstract 23 January 2024 Pages: 2276 - 2277
ASO Visual Abstract: Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer Ashley A. WoodfinClinton YamSusie X. Sun ASO Visual Abstract 11 January 2024 Pages: 2278 - 2279
ASO Visual Abstract: Long-Term Patient-Reported Arm Symptoms in Breast Cancer Survivors Alison LawsMirelle LagendijkLaura S. Dominici ASO Visual Abstract 11 January 2024 Pages: 2280 - 2281
ASO Visual Abstract: Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype? Natália PolidorioGiacomo MontagnaMonica Morrow ASO Visual Abstract 11 January 2024 Pages: 2282 - 2282
ASO Visual Abstract: Breast Cancer Screening and BI-RADS Scoring Trends Before and During the COVID-19 Pandemic in an Academic Safety-Net Hospital Anna Kobzeva-HerzogThomas O’SheaMichael R. Cassidy ASO Visual Abstract 22 January 2024 Pages: 2283 - 2283
ASO Visual Abstract: Defining the Biology of Estrogen Receptor-Low Positive Breast Cancer Tessa HigginsOlga KantorElizabeth A. Mittendorf ASO Visual Abstract 24 January 2024 Pages: 2284 - 2285
Impact of Commission on Cancer Accreditation on Cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis Armaan AhmedJennifer WhittingtonZahra Shafaee Global Health Services Research 13 December 2023 Pages: 2286 - 2294
Surgeon Perspectives on the Management of Aborted Cancer Surgery: Results of a Society of Surgical Oncology Member Survey Alexandra G. Lopez-AguiarAngela SarnaJordan M. Cloyd Global Health Services Research 21 December 2023 Pages: 2295 - 2302
ASO Author Reflections: Commission on Cancer Accreditation as an Independent Predictor of Cancer Survival Armaan AhmedJennifer WhittingtonZahra Shafaee ASO Author Reflections 23 December 2023 Pages: 2303 - 2303
ASO Author Reflections: Understanding Surgeon Perspectives on the Management of Aborted Cancer Surgery Rakhsha KhatriJordan M. Cloyd ASO Author Reflections 10 January 2024 Pages: 2304 - 2305
ASO Visual Abstract: Surgeon Perspectives on the Management of Aborted Cancer Surgery: Results of an SSO Member Survey Alexandra G. Lopez-AguiarAngela SarnaJordan M. Cloyd ASO Visual Abstract 12 January 2024 Pages: 2306 - 2307
ASO Visual Abstract: Conditional Relative Survival of Exocrine Pancreatic Cancer—A Population-Based Study Mee Joo KangJohyun HaSung-Sik Han ASO Visual Abstract 02 January 2024 Pages: 2308 - 2308
Prognostic Impact of Stromal Profiles Educated by Gastric Cancer Kazunori TakahashiKatsutoshi ShodaDaisuke Ichikawa Translational Research 02 November 2023 Pages: 2309 - 2318
Circulating Tumor DNA in the Immediate Postoperative Setting Vasileios EfthymiouNatalia QueenanDaniel L. Faden Translational Research 08 January 2024 Pages: 2319 - 2325
ASO Author Reflections: Loss of Intestinal Integrity During Oncological Surgery and Postoperative Complications: A Complex Relationship Sharon HendriksBarbara L. van LeeuwenJacco J. De Haan ASO Author Reflections Open access 22 January 2024 Pages: 2326 - 2327
ASO Author Reflections: Diversity of Cancer-Associated Fibroblasts Produced by Gastric Cancer Cells Kazunori TakahashiKatsutoshi ShodaDaisuke Ichikawa ASO Author Reflections 25 November 2023 Pages: 2328 - 2329
ASO Visual Abstract: Prognostic Impact of Stromal Profiles Educated by Gastric Cancer Kazunori TakahashiKatsutoshi ShodaDaisuke Ichikawa ASO Visual Abstract 13 January 2024 Pages: 2330 - 2331
ASO Visual Abstract: Characterizing the Immune Environment in Peritoneal Carcinomatosis—Insights for Novel Immunotherapy Strategies Patrick L. WagnerChelsea M. KnottsDavid L. Bartlett ASO Visual Abstract 24 January 2024 Pages: 2332 - 2333
ASO Visual Abstract: Cancer-Associated Fibroblasts Together with a Decline in CD8+ T Cells Predict a Worse Prognosis for Breast Cancer Patients Hyung Suk KimYung-Kyun NohJeong-Yeon Lee ASO Visual Abstract 17 January 2024 Pages: 2334 - 2335
ASO Visual Abstract: Circulating Tumor DNA in the Immediate Postoperative Setting Vasileios EfthymiouNatalia QueenanDaniel L. Faden ASO Visual Abstract 05 February 2024 Pages: 2336 - 2336
Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors Aradhya NigamJanet W. Y. LiBrian R. Untch Endocrine Tumors 30 November 2023 Pages: 2337 - 2348
The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer Seok-ki KimJungirl SeokYuh-Seog Jung Endocrine Tumors 02 February 2024 Pages: 2349 - 2356
Modified Radical Neck Dissection for Papillary Thyroid Carcinoma via a Combined Endoscopy Approach: The Transoral Approach and the Chest Approach Duy Quoc NgoDuong The LeQuang Van Le Endocrine Tumors 10 January 2024 Pages: 2357 - 2358
ASO Author Reflections: Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors Aradhya NigamBrian R. Untch ASO Author Reflections 22 January 2024 Pages: 2359 - 2360
ASO Visual Abstract: Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic, Well-Differentiated, Small-Bowel Neuroendocrine Tumors Aradhya NigamJanet W. Y. LiBrian R. Untch ASO Visual Abstract 24 December 2023 Pages: 2361 - 2362
ASO Visual Abstract: Feasibility of Autofluorescence Using Overlay Imaging for the Detection of Parathyroid Glands: Defining Standards Melisa ArikanJosef HegazyPhilipp Riss ASO Visual Abstract 19 January 2024 Pages: 2363 - 2363
ASO Visual Abstract: The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer Seok-ki KimJungirl SeokYuh-Seog Jung ASO Visual Abstract 31 January 2024 Pages: 2364 - 2365
ASO Visual Abstract: The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study Jia-ying ChenNai-si HuangQing-hai Ji ASO Visual Abstract 19 January 2024 Pages: 2366 - 2367
Cytoreductive Surgery with Bidirectional Intraoperative Chemotherapy (BDIC) Using Intravenous Ifosfamide Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Sarcomatosis: A Retrospective Cohort Study Mohammed S. AlmasriHakeam A. HakeamTarek M. Amin Peritoneal Surface Malignancy 03 January 2024 Pages: 2368 - 2377